# SMS Pharmaceuticals (NSE: SMSPHARMA) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/SMSPHARMA · Pivot · prices to 22 Oct 2026

SMS Pharmaceuticals (NSE: SMSPHARMA) closed at ₹434.55 on 22 Oct 2026, up 0.59% on the day. With a market capitalisation of ₹4,070 Cr, it ranks 863rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - General.

At its last close the stock traded at 39× trailing earnings, against a return on equity of 10.8% in FY25. Over the past year the share price has risen 59.0%. Its 52-week range is ₹270.10 (24 Nov 2025) to ₹494.45 (22 Sep 2026); the last close is 12.1% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹207 Cr (+5.6% year on year) and net profit ₹20 Cr (+8.0%), on a consolidated basis. Promoters held 68.07% of the company as of 30 Jun 2026; 17.99% of promoter shares were pledged.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹434.55 |
| Market cap | ₹4,070 Cr |
| P/E (trailing) | 39 |
| ROE | 10.8% (FY25) |
| ROCE | 13.4% (FY25) |
| Debt to equity | 0.49 |
| 52-week high | ₹494.45 (22 Sep 2026) |
| 52-week low | ₹270.10 (24 Nov 2025) |
| 1-year return | +59.0% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q1 FY27 | ₹207 Cr | +5.6% | ₹20 Cr | +8.0% | ₹2.23 |
| Q4 FY26 | ₹238 Cr | −4.1% | ₹21 Cr | +4.4% | ₹3.58 |
| Q3 FY26 | ₹210 Cr | +21.4% | ₹23 Cr | +35.8% | ₹2.59 |
| Q2 FY26 | ₹242 Cr | +23.2% | ₹25 Cr | +81.3% | ₹2.84 |
| Q1 FY26 | ₹196 Cr | +19.2% | ₹19 Cr | +14.3% | ₹2.31 |
| Q4 FY25 | ₹248 Cr | +1.0% | ₹20 Cr | +25.1% | ₹2.40 |
| Q3 FY25 | ₹173 Cr | +7.4% | ₹17 Cr | +39.0% | ₹2.15 |
| Q2 FY25 | ₹197 Cr | +18.1% | ₹14 Cr | +15.0% | ₹1.67 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹783 Cr | ₹67 Cr |
| FY24 | ₹709 Cr | ₹49 Cr |
| FY23 | ₹522 Cr | ₹4 Cr |
| FY22 | ₹520 Cr | ₹68 Cr |
| FY21 | ₹563 Cr | ₹61 Cr |
| FY20 | ₹412 Cr | ₹33 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 68.07%
- Foreign institutions: 0.65%
- Domestic institutions: 2.83%
- Non-institutions: 28.45%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Zota Health Care](https://app.pivotnow.in/stock/ZOTA) | ₹1,304.00 | ₹4,516 Cr | — | — |
| [Jeena Sikho Lifecare](https://app.pivotnow.in/stock/JSLL) | ₹360.05 | ₹4,475 Cr | 20.3 | — |
| [Novartis India](https://app.pivotnow.in/stock/NOVARTIND) | ₹1,810.70 | ₹4,471 Cr | 48 | — |
| [Orchid Pharma](https://app.pivotnow.in/stock/ORCHPHARMA) | ₹876.25 | ₹4,444 Cr | 214.2 | — |
| [Gufic Biosciences](https://app.pivotnow.in/stock/GUFICBIO) | ₹401.55 | ₹4,027 Cr | 62.7 | — |
| [Gujarat Themis Biosyn](https://app.pivotnow.in/stock/GUJTHEM) | ₹365.70 | ₹3,985 Cr | 85.4 | — |

## Questions and answers

### What is the share price of SMS Pharmaceuticals today?

SMS Pharmaceuticals (NSE: SMSPHARMA) last closed at ₹434.55 on 22 Oct 2026. Its 52-week high is ₹494.45 and its 52-week low is ₹270.10.

### What is the market cap of SMS Pharmaceuticals?

SMS Pharmaceuticals' market capitalisation is ₹4,070 Cr (₹4,070 Cr) at the 22 Oct 2026 close, ranking 863rd among the NSE companies Pivot tracks.

### What is the P/E ratio of SMS Pharmaceuticals?

SMS Pharmaceuticals trades at a trailing P/E of 39. The median P/E of the 5 closest Pharma & Healthcare peers by market cap is 62.7.

### What is the ROE and ROCE of SMS Pharmaceuticals?

Return on equity was 10.8% in FY25 and return on capital employed was 13.4% in FY25 (consolidated figures).

### Is SMS Pharmaceuticals a debt-free company?

No. SMS Pharmaceuticals' debt-to-equity ratio was 0.49 in FY25, with total debt of ₹139 Cr.

### What were SMS Pharmaceuticals' latest quarterly results?

For Q1 FY27 (quarter ended 30 Jun 2026), SMS Pharmaceuticals reported revenue of ₹207 Cr, +5.6% year on year, and net profit of ₹20 Cr, +8.0% year on year.

### How has SMS Pharmaceuticals stock performed over the last year?

SMS Pharmaceuticals' share price has risen 59.0% over the past year, +12.6% over three months and −7.2% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of SMS Pharmaceuticals?

As of 30 Jun 2026: promoters 68.07%, foreign institutions 0.65%, domestic institutions 2.83%, non-institutions 28.45%. 17.99% of promoter shares were pledged.

### Who are SMS Pharmaceuticals' competitors?

The listed Pharma & Healthcare companies closest to SMS Pharmaceuticals by market cap are Zota Health Care, Jeena Sikho Lifecare, Novartis India, Orchid Pharma, Gufic Biosciences and Gujarat Themis Biosyn.

### Is SMS Pharmaceuticals a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out SMS Pharmaceuticals' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SMSPHARMA against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.